Neuropharmacology of the essential oil of bergamot

Fitoterapia

Volumn 81, Issue 6, 2010, Pages 453-461

  Bagetta, Giacinto ^a   Morrone, Luigi Antonio ^a   Rombolà, Laura ^a   Amantea, Diana ^a   Russo, Rossella ^a   Berliocchi, Laura ^b   Sakurada, Shinobu ^c   Sakurada, Tsukasa ^d   Rotiroti, Domenicantonio ^b   Corasaniti, Maria Tiziana ^b  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^d DAIICHI UNIVERSITY OF PHARMACY   (Japan)

Author keywords

Akt; Brain ischemia (MCAO); EEG spectrum power; Essential oil of bergamot (BEO); GSK 3 ; Neurotransmitter release; Pain

Indexed keywords

BERGAMOT OIL; ESSENTIAL OIL; NEUROTRANSMITTER;

ALTERNATIVE MEDICINE; ANXIETY; BRAIN ISCHEMIA; CHRONIC PAIN; DEPRESSION; DRUG MECHANISM; EXOCYTOSIS; HIPPOCAMPUS; NERVE CELL PLASTICITY; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; CITRUS; HUMANS; NEUROPHARMACOLOGY; OILS, VOLATILE; SYNAPTIC TRANSMISSION;

CITRUS AURANTIUM BERGAMIA; MAMMALIA;

EID: 77955711210     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2010.01.013     Document Type: Review

References (76)

1. L. Mondello, I. Stagno d'Alcontres, R. Del Duce, and F. Crispo On the genuineness of citrus essential oils, Part XL. The composition of the coumarins and psoralens of calabrian bergamot essential oil (Citrus bergamia Risso) Flav Fragr J 8 1993 17 24
2. P. Dugo, L. Mondello, L. Dugo, R. Stancanelli, and G. Dugo LC-MS for the identification of oxygen heterocyclic compounds in citrus essential oils J Pharm Biomed Anal 24 2000 147 150
3. L. Mondello, P. Dugo, K.D. Bartle, G. Dugo, and A. Cotroneo Automated HPLC-HRGC: a powerful method for essential oils analysis. Part V. Identification of terpene hydrocarbons of bergamot, lemon, mandarin, sweet orange, bitter orange, grapefruit, clementine and mexican lime oils by coupled HPLC-HRGCMS (ITD) Flav Fragr J 10 1995 33 42
4. A. Verzera, G. Lamonica, L. Mondello, A. Trozzi, and G. Dugo The composition of bergamot oil Perfum Flavor 21 1996 19 34
5. A. Verzera, A. Trozzi, F. Gazea, G. Cicciarello, and A. Cotroneo Effects of rootstock on the composition of bergamot (Citrus bergamia Risso et Poiteau) essential oil J Agric Food Chem 51 2003 206 210
6. S.T. Zaynoun, B.E. Johnson, and W. Frain-Bell A study of oil of bergamot and its importance as a phototoxic agent. I. Characterization and quantification of the photoactive component Br J Dermatol 96 1977 475 482
7. M.J. Ashwood-Smith, G.A. Poulton, M. Barker, and M. Mildenberger Methoxypsoralen, an ingredient in several suntan preparations, has lethal, mutagenic and clastogenic properties Nature 285 1980 407 409
8. J. Lehrner, C. Eckersberger, P. Walla, G. Potsch, and L. Deecke Ambient odor of orange in a dental office reduces anxiety and improves mood in female patients Physiol Behav 71 2000 83 86
9. T. Komori, R. Fujiwara, M. Tanida, and J. Nomura Potential antidepressant effects of lemon odor in rats Eur Neuropsychopharmacol 5 1995 477 480
10. J. Smallwood, R. Brown, F. Coulter, E. Irvine, and C. Copland Aromatherapy and behaviour disturbanced in dementia: a randomized controlled trial Int J Geriatr Psychiatry 16 2001 1010 1013
11. A.M. Aloisi, I. Ceccarelli, F. Masi, and A. Scaramuzzino Effects of the essential oil from citrus lemon in male and female rats exposed to a persistent painful stimulation Behav Brain Res 36 2002 127 135
12. E. Barocelli, F. Calcina, M. Chiavarini, M. Impicciatore, R. Bruni, A. Bianchi, and V. Ballabeni Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon "Grosso" essential oil Life Sci 76 2004 213 223
13. D.J. Brooker, M. Snape, E. Johnson, D. Ward, and M. Payne Single case evaluation of the effects of aromatherapy and massage on disturbed behaviour in severe dementia Br J Clin Psychol 36 1997 287 296
14. L.O. Orafidiya, E.O. Agbani, E.O. Iwalewa, K.A. Adelusola, and O.O. Oyedapo Studies on the acute and sub-chronic toxicity of the essential oil of Ocimum gratissimum L. leaf Phytomedicine 11 2004 71 76
15. N. Perry, and E. Perry Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives CNS Drugs 20 2006 257 280
16. H. Berger Über des Elektrenkephalogramm des Menschen Arch Psychiatr Nervenkr 87 1929 527 570
17. G. Bagetta, G. De Sarro, E. Priolo, and G. Nisticò Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats Br J Pharmacol 95 1988 860 866
18. L. Rombolá, M.T. Corasaniti, D. Rotiroti, C. Tassorelli, S. Sakurada, G. Bagetta, and L.A. Morrone Effects of systemic administration of the essential oil of bergamot (BEO) on gross behaviour and EEG power spectra recorded from the rat hippocampus and cerebral cortex Funct Neurol 24 2009 107 112
19. M.A. Diego, N.A. Jones, T. Field, M. Hernandez-Reif, S. Schanberg, C. Kuhn, V. McAdam, R. Galamaga, and M. Galamaga Aromatherapy positively affects mood, EEG patterns of alertness and math computations Int J Neurosci 96 1998 217 224
20. M. Moss, J. Cook, K. Wesnes, and P. Duckett Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults Int J Neurosci 113 2003 15 38
21. H. Sugano Psychophysiological studies of fragrances Perfumery: The Psychology and Biology of Fragrance 1988 Chapman and Hill New York 221 228
22. K. Semba The cholinergic basal forebrain: a critical role in cortical arousal Adv Exp Med Biol 295 1991 197 218
23. I. Ceccarelli, F. Masi, P. Fiorenzani, and A.M. Aloisi Sex differences in the citrus lemon essential oil-induced increase of hippocampal acetylcholine release in rats exposed to a persistent painful stimulation Neurosci Lett 330 2002 25 28
24. I.D. Manns, A. Alonso, and B.E. Jones Rhythmically discharging basal forebrain units comprise cholinergic, GABAergic, and putative glutamatergic cells J Neurophysiol 89 2003 1057 1066
25. H.W. Boddeke, R. Best, and P.H. Boeijinga Synchronous 20 Hz rhythmic activity in hippocampal networks induced by activation of metabotropic glutamate receptors in vitro Neuroscience 76 1997 653 658
26. L.A. Morrone, L. Rombola, M.T. Corasaniti, S. Zappettini, P. Paudice, G. Bonanno, and G. Bagetta The essential oil of bergamot enhances the levels of amino acid neurotransmitters in the hippocampus of rat: implication of monoterpene hydrocarbons Pharmacol Res 55 2007 255 262
27. M. Raiteri, G. Bonanno, M. Marchi, and G. Maura Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J Pharmacol Exp Ther 231 1984 671 677
28. L. Raiteri, and M. Raiteri Synaptosomes still viable after 25 years of superfusion Neurochem Res 25 2000 1265 1274
29. K. Shimamoto, B. Lebrun, Y. Yasuda-Kamatani, M. Sakaitani, Y. Shigeri, N. Yumoto, and T. Nakajima DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters Mol Pharmacol 53 1998 195 201
30. L.K. Bak, A. Schousboe, and H.S. Waagepetersen Characterization of depolarization-coupled release of glutamate from cultured mouse cerebellar granule cells using DL-threo-beta-benzyloxyaspartate (DL-TBOA) to distinguish between the vesicular and cytoplasmic pools Neurochem Int 43 2003 417 424
31. C. Bonde, A. Sarup, A. Schousboe, G. Gegelashvili, J. Zimmer, and J. Noraberg Neurotoxic and neuroprotective effects of the glutamate transporter inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) during physiological and ischemia-like conditions Neurochem Int 43 2003 371 380
32. D. Attwell, B. Barbour, and M. Szatkowski Nonvesicular release of neurotransmitter Neuron 11 1993 401 407
33. G. Levi, and M. Raiteri Carrier-mediated release of neurotransmitters Trends Neurosci 16 1993 415 419
34. D.J. Rossi, T. Oshima, and D. Attwell Glutamate release in severe brain ischaemia is mainly by reversed uptake Nature 403 2000 316 321
35. D. Amantea, V. Fratto, S. Maida, D. Rotiroti, S. Ragusa, G. Nappi, G. Bagetta, and M.T. Corasaniti Prevention of glutamate accumulation and upregulation of phospho-akt may account for neuroprotection afforded by bergamot essential oil against brain injury induced by focal cerebral ischemia in rat Int Rev Neurobiol 85 2009 389 405
36. M.T. Corasaniti, J. Maiuolo, S. Maida, V. Fratto, M. Navarra, R. Russo, D. Amantea, L.A. Morrone, and G. Bagetta Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro Br J Pharmacol 151 2007 518 529
37. D.R. Alessi, M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B.A. Hemming Mechanism of activation of protein kinase B by insulin and IGF-1 Embo J 15 1996 6541 6551
38. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovic, and B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
39. P.C. van Weeren, K.M. De Bruyn, A.M. De Vries-Smits, J. van Lint, and B.M. Burgering Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB J Biol Chem 273 1998 13150 13156
40. D.P. Brazil, and B.A. Hemmings Ten years of protein kinase B signalling: a hard Akt to follow Trends Biochem Sci 26 2001 657 664
41. M.H. Cardone, N. Roy, H.R. Stennicke, G.S. Salvesen, T.F. Franke, E. Stanbridge, S. Frisch, and J.C. Reed Regulation of cell death protease caspase-9 by phosphorylation Science 282 1998 1318 1321
42. C.A. Grimes, and R.S. Jope The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling Prog Neurobiol 65 2001 391 426
43. D. Amantea, R. Russo, G. Bagetta, and M.T. Corasaniti From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens Pharmacol Res 52 2005 119 132
44. K. Fukunaga, and T. Kawano Akt is a molecular target for signal transduction therapy in brain ischemic insult J Pharmacol Sci 92 2003 317 327 (Pubitemid 37098256)
45. H. Zhao, T. Shimohata, J.Q. Wang, G. Sun, D.W. Schaal, R.M. Sapolsky, and G.K. Steinberg Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats J Neurosci 25 2005 9794 9806
46. C.J. Vlahos, W.F. Matter, K.Y. Hui, and R.F. Brown A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4- one (LY294002) J Biol Chem 269 1994 5241 5248
47. C.J. Woolf, and M.W. Salter Neuronal plasticity: increasing the gain in pain Science 288 2000 1765 1769
48. R.R. Ji, and G. Strichartz Cell signaling and the genesis of neuropathic pain Sci STKE 2004 reE14
49. D. Julius, and A.I. Basbaum Molecular mechanisms of nociception Nature 413 2001 203 210
50. R. Dingledine, K. Borges, D. Bowie, and S.F. Traynelis The glutamate receptor ion channels Pharmacol Rev 51 1999 7 61
51. D. Bleakman, A. Alt, and E.S. Nisenbaum Glutamate receptors and pain Semin Cell Dev Biol 17 2006 592 604
52. D.G. Brown, and J.J. Krupp N-Methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics Curr Top Med Chem 6 2006 749 770
53. A.B. Petrenko, T. Yamakura, H. Baba, and K. Shimoji The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review Anesth Analg 97 2003 1108 1116
54. K.W. Muir Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists Curr Opin Pharmacol 6 2006 53 60
55. P.F. Smith Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation? Curr Opin Investig Drugs 4 2003 826 832
56. A.T. Ferrell-Torry, and O.J. Glick The use of therapeutic massage as a nursing intervention to modify anxiety and the perception of cancer pain Cancer Nurs 16 1993 93 101
57. J. Glover, S. Dibble, M.J. Dodd, and C. Miaskowski Mood states of oncology outpatients: does pain make difference ? J Pain Symptom Manag 10 1995 120 128
58. S.M. Wilkinson, S.B. Love, A.M. Westcombe, M.A. Gambles, C.C. Burgess, and A. Cargill Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer. A multicenter randomized controlled trial J Clin Oncol 25 2007 532 539
59. T. Sakurada, K. Katsumata, K. Tan-No, S. Sakurada, and K. Kisara The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord Neuropharmacology 31 1992 1279 1285
60. T. Sakurada, H. Yogo, K. Katsumata, K. Tan-No, S. Sakurada, and K. Kisara Differential antinociceptive effects of sendide, a NK1-receptor antagonist, and morphine in the capsaicin test Brain Res 646 1994 319 322
61. V. Di Marzo, P.M. Blumberg, and A. Szallasi Endovanilloid signaling in pain Curr Opin Neurobiol 12 2002 372 379
62. A. Szallasi, D.N. Cortright, C.A. Blum, and S.R. Eid The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof- concept Nat Rev 6 2007 357 372
63. P. Holzer Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons Pharmacol Rev 43 1991 143 201
64. T. Kawamata, K. Omoto, M. Toriyabe, M. Kawamata, and A. Namiki Involvement of capsaicin-sensitive fibers in spinal NMDA-induced glutamate release NeuroReport 12 2001 3447 3450
65. L.S. Sorkin, and D.J. McAdoo Amino acids and serotonin are released into the lumbar spinal cord of the anesthetized cat following intradermal capsaicin injections Brain Res 607 1993 89 98
66. T. Sakurada, K. Wako, A. Sugiyama, C. Sakurada, K. Tan-No, and K. Kisara Involvement of spinal NMDA receptors in capsaicin-induced nociception Pharmacol Biochem Behav 59 1998 339 345
67. X. Zou, Q. Lin, and W.D. Willis Enhanced phosphorylation of NMDA receptor 1 subunits in spinal cord dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats J Neurosci 20 2000 6989 6997
68. Y. Kawasaki, T. Kohno, Z.Y. Zhuang, G.J. Brenner, H. Wang, C. van Der Meer, K. Befort, C.J. Woolf, and C.J. Woolf Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization J Neurosci 24 2004 8310 8321
69. T. Sakurada, H. Kuwahata, H. Katsuyama, S. Katsuyama, T. Komatsu, and L.A. Morrone Intraplantar injection of bergamot essential oil into the mouse hindpaw: effects on capsaicin-induced nociceptive behaviors Int Rev Neurobiol 85 2009 235 246
70. A.T. Peana, M.G. De Montis, E. Nieddu, T.M. Spano, S. Sechi, P.S. D'Aquila, and P. Pippia Profile of spinal and supra-spinal antinociception of (-)-linalool Eur J Pharmacol 485 2004 165 174
71. D. Bian, M.L. Nichols, M.H. Ossipov, J. Lai, and F. Porreca Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats NeuroReport 6 1995 1981 1994
72. Y.W. Lee, S.R. Chaplan, and T.L. Yaksh Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model Neurosci Lett 199 1995 111 114
73. J. Mao, D.D. Price, and D.J. Mayer Experimental mononeuropathy reduces the antinociceptive effects of morphine: Implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain Pain 61 1995 353 364
74. M.H. Ossipov, Y. Lopez, M.L. Nichols, D. Bian, and F. Porreca The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive Neurosci Lett 199 1995 87 90
75. L. Berliocchi, R. Russo, A. Levato, V. Fratto, G. Bagetta, S. Sakurada, T. Sakurada, N.B. Mercuri, and M.T. Corasaniti (-)-Linalool attenuates allodynia in neuropathic pain induced by spinal nerve ligation in C57/BL6 mice Int Rev Neurobiol 85 2009 221 235
76. L. Mondello, A. Verzera, P. Previti, F. Crispo, and G. Dugo Multidimensional capillary GC-GC for the analysis of complex samples. 5. Enantiomeric distribution of monoterpene hydrocarbons, monoterpene alcohols, and linalyl acetate of Bergamot (Citrus bergamia Risso et Poiteau) oils J Agric Food Chem 46 1998 4275 4282 (Pubitemid 128488528)